These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23354585)

  • 21. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy.
    Liu Y; Yan R; Song A; Niu X; Cao C; Wei J; Dong X; Gao D
    Am J Hypertens; 2014 Feb; 27(2):268-78. PubMed ID: 24304656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study.
    Basile J; Babazadeh S; Lillestol M; Botha J; Yurkovic C; Weitzman R
    J Clin Hypertens (Greenwich); 2011 Mar; 13(3):162-9. PubMed ID: 21366847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of aliskiren/amlodipine single-pill combinations in patients who did not respond fully to amlodipine monotherapy¥.
    Pfeiffer D; Rennie N; Papst CC; Zhang J
    Curr Vasc Pharmacol; 2012 Nov; 10(6):773-80. PubMed ID: 22303911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aliskiren/hydrochlorothiazide combination: in mild to moderate hypertension.
    Baldwin CM; Plosker GL
    Drugs; 2009; 69(7):833-41. PubMed ID: 19441870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide alone.
    Geiger H; Barranco E; Gorostidi M; Taylor A; Zhang X; Xiang Z; Zhang J
    J Clin Hypertens (Greenwich); 2009 Jun; 11(6):324-32. PubMed ID: 19527323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial.
    Andersen K; Weinberger MH; Egan B; Constance CM; Wright M; Lukashevich V; Keefe DL
    Cardiovasc Ther; 2010 Dec; 28(6):344-9. PubMed ID: 20406241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effectiveness of aliskiren for the 'real-world' management of hypertension: multilevel modelling of 180-day blood pressure outcomes (the Belgian DRIVER Study).
    Verpooten GA; Aerts A; Coen N; Vancayzeele S; Hermans C; Bowles J; MacDonald K; Abraham I; Lee CS
    Int J Clin Pract; 2011 Jan; 65(1):54-63. PubMed ID: 21155943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
    Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Smith B; Weissbach N; Maboudian M; Botha J; van Ingen H
    Circulation; 2009 Jan; 119(3):417-25. PubMed ID: 19139391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension.
    Kushiro T; Itakura H; Abo Y; Gotou H; Terao S; Keefe DL
    Hypertens Res; 2006 Dec; 29(12):997-1005. PubMed ID: 17378372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
    Yarows SA; Oparil S; Patel S; Fang H; Zhang J
    Adv Ther; 2008 Dec; 25(12):1288-302. PubMed ID: 19066757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with aliskiren/amlodipine combination in patients with moderate-to-severe hypertension: a randomised, double-blind, active comparator trial.
    Braun-Dullaeus RC; Shustov SB; Alvarez C; Rogelio GG; Zhang J; Hristoskova S; Häring DA
    Int J Clin Pract; 2012 Sep; 66(9):834-42. PubMed ID: 22897460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Essential Hypertension (RESOLVE): A Large, Observational, Retrospective, Cohort Study.
    Park SJ; Rhee SJ
    Adv Ther; 2020 Aug; 37(8):3500-3514. PubMed ID: 32557349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial.
    Ferdinand KC; Pool J; Weitzman R; Purkayastha D; Townsend R
    J Clin Hypertens (Greenwich); 2011 May; 13(5):366-75. PubMed ID: 21545398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
    Axthelm C; Sieder C; Meister F; Kaiser E
    Curr Med Res Opin; 2012 Jan; 28(1):69-78. PubMed ID: 22117838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of the direct renin inhibitor, aliskiren, in patients with resistant hypertension.
    Yoshitomi Y; Kawanishi K; Yamaguchi A; Sakurai S; Minai K; Ishii T; Tarutani Y; Tsujibayashi T; Kaneki M; Saitou Y; Suwa S
    Int Heart J; 2013; 54(2):88-92. PubMed ID: 23676368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
    Pool JL; Glazer R; Crikelair N; Levy D
    Clin Drug Investig; 2009; 29(12):791-802. PubMed ID: 19888785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.